Literature DB >> 30523563

When kidneys and lungs suffer together.

Claudio Sorino1, Nicola Scichilone2, Claudio Pedone3, Stefano Negri4, Dina Visca5, Antonio Spanevello4,5.   

Abstract

A significant interaction between kidneys and lungs has been shown in physiological and pathological conditions. The two organs can both be targets of the same systemic disease (eg., some vasculitides). Moreover, loss of normal function of either of them can induce direct and indirect dysregulation of the other one. Subjects suffering from COPD may have systemic inflammation, hypoxemia, endothelial dysfunction, increased sympathetic activation and increased aortic stiffness. As well as the exposure to nicotine, all the foresaid factors can induce a microvascular damage, albuminuria, and a worsening of renal function. Renal failure in COPD can be unrecognized since elderly and frail patients may have normal serum creatinine concentration. Lungs and kidneys participate in maintaining the acid-base balance. Compensatory role of the lungs rapidly expresses through an increase or reduction of ventilation. Renal compensation usually requires a few days as it is achieved through changes in bicarbonate reabsorption. Chronic kidney disease and end-stage renal diseases increase the risk of pneumonia. Vaccination against Streptococcus pneumonia and seasonal influenza is recommended for these patients. Vaccines against the last very virulent H1N1 influenza A strain are also available and effective. Acute lung injury and acute kidney injury are frequent complications in critical illnesses, associated with high morbidity and mortality. The concomitant failure of kidneys and lungs implies a multidisciplinary approach, both in terms of diagnostic processes and therapeutic management.

Entities:  

Keywords:  Acute kidney injury; Acute lung injury; COPD; Mechanical ventilation; Pulmonary-renal syndrome

Mesh:

Year:  2018        PMID: 30523563     DOI: 10.1007/s40620-018-00563-1

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  74 in total

1.  Interstitial Lung Disease After Kidney Transplantation and the Role of Everolimus.

Authors:  A Solazzo; C Botta; F Nava; A Baisi; D Bonucchi; G Cappelli
Journal:  Transplant Proc       Date:  2016-03       Impact factor: 1.066

Review 2.  Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis.

Authors:  Simon J Davies; Patrik Španěl; David Smith
Journal:  Bioanalysis       Date:  2014-03       Impact factor: 2.681

3.  Gases as uremic toxins: is there something in the air?

Authors:  Joachim Jankowski; Timm Westhof; Nosratola D Vaziri; Diego Ingrosso; Alessandra F Perna
Journal:  Semin Nephrol       Date:  2014-02-18       Impact factor: 5.299

4.  Pulmonary function in non-insulin-dependent diabetes mellitus.

Authors:  M Marvisi; L Bartolini; P del Borrello; M Brianti; G Marani; A Guariglia; A Cuomo
Journal:  Respiration       Date:  2001       Impact factor: 3.580

5.  Pulmonary complications in renal recipients after transplantation.

Authors:  E Kupeli; G Ulubay; T Colak; T S Ozdemirel; B A Ozyurek; S Akcay; M Haberal
Journal:  Transplant Proc       Date:  2011-03       Impact factor: 1.066

Review 6.  ANCA-associated vasculitis with renal involvement.

Authors:  Valentina Binda; Gabriella Moroni; Piergiorgio Messa
Journal:  J Nephrol       Date:  2017-05-30       Impact factor: 3.902

Review 7.  Efficacy of pneumococcal immunization in patients with renal disease--what is the data?

Authors:  Joan Robinson
Journal:  Am J Nephrol       Date:  2004-07-20       Impact factor: 3.754

8.  Relationship of metabolic alkalosis, azotemia and morbidity in patients with chronic obstructive pulmonary disease and hypercapnia.

Authors:  Irfan Ucgun; Funda Oztuna; Canan Eren Dagli; Huseyin Yildirim; Cengiz Bal
Journal:  Respiration       Date:  2008-05-08       Impact factor: 3.580

9.  Predictors of mortality of patients with acute respiratory failure secondary to chronic obstructive pulmonary disease admitted to an intensive care unit: a one year study.

Authors:  G C Khilnani; Amit Banga; S K Sharma
Journal:  BMC Pulm Med       Date:  2004-11-27       Impact factor: 3.317

10.  Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD.

Authors:  Michelle John; Samia Hussain; Andrew Prayle; Rebecca Simms; John R Cockcroft; Charlotte E Bolton
Journal:  Respir Res       Date:  2013-03-05
View more
  8 in total

Review 1.  Is There an Association Between Chronic Obstructive Pulmonary Disease and Chronic Renal Failure?

Authors:  Nikolaos Madouros; Sommer Jarvis; Amber Saleem; Evgenia Koumadoraki; Shayka Sharif; Safeera Khan
Journal:  Cureus       Date:  2022-06-21

Review 2.  Prolonged Mechanical Ventilation: Outcomes and Management.

Authors:  Hung-Yu Huang; Chih-Yu Huang; Li-Fu Li
Journal:  J Clin Med       Date:  2022-04-27       Impact factor: 4.964

Review 3.  Molecular Characteristics and Treatment of Endothelial Dysfunction in Patients with COPD: A Review Article.

Authors:  Botond Szucs; Csilla Szucs; Mate Petrekanits; Janos T Varga
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

Review 4.  Cardiovascular Functional Changes in Chronic Kidney Disease: Integrative Physiology, Pathophysiology and Applications of Cardiopulmonary Exercise Testing.

Authors:  Kenneth Lim; Gordon McGregor; Andrew R Coggan; Gregory D Lewis; Sharon M Moe
Journal:  Front Physiol       Date:  2020-09-15       Impact factor: 4.566

5.  Change for the Better: Severe Pneumonia at the Emergency Department.

Authors:  Dariusz Kawecki; Anna Majewska; Jarosław Czerwinski
Journal:  Pathogens       Date:  2022-07-08

Review 6.  Trends, Advantages and Disadvantages in Combined Extracorporeal Lung and Kidney Support From a Technical Point of View.

Authors:  Ana Martins Costa; Frank Halfwerk; Bettina Wiegmann; Michael Neidlin; Jutta Arens
Journal:  Front Med Technol       Date:  2022-06-21

Review 7.  Sympathetic activation: a potential link between comorbidities and COVID-19.

Authors:  Andrea Porzionato; Aron Emmi; Silvia Barbon; Rafael Boscolo-Berto; Carla Stecco; Elena Stocco; Veronica Macchi; Raffaele De Caro
Journal:  FEBS J       Date:  2020-08-01       Impact factor: 5.542

8.  Diagnostic potential of circulating cell-free microRNAs for community-acquired pneumonia and pneumonia-related sepsis.

Authors:  Stefanie Hermann; Florian Brandes; Benedikt Kirchner; Dominik Buschmann; Melanie Borrmann; Matthias Klein; Stefan Kotschote; Michael Bonin; Marlene Reithmair; Ines Kaufmann; Gustav Schelling; Michael W Pfaffl
Journal:  J Cell Mol Med       Date:  2020-09-11       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.